Interleukin-6 (IL-6)-174 G/C polymorphism--lack of association with inflammatory and haemostatic variables in patients with coronary heart disease treated with atorvastatin and quinapril.
Potaczek
Daniel P
DP
Undas
Anetta
A
Szczeklik
Andrew
A
D000704:Analysis of Variance; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000069059:Atorvastatin; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000235:genetics*; D003596:Cytosine; D004359:Drug Therapy, Combination; D005838:Genotype; D006147:Guanine; D006487:Hemostasis / Q000187:drug effects / Q000235:genetics; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D018836:Inflammation Mediators / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000187:drug effects; D011758:Pyrroles / Q000627:therapeutic use*; D000077583:Quinapril; D044005:Tetrahydroisoquinolines / Q000627:therapeutic use*; D016896:Treatment Outcome
D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018836:Inflammation Mediators; D015850:Interleukin-6; D011758:Pyrroles; D044005:Tetrahydroisoquinolines; D006147:Guanine; D003596:Cytosine; D000069059:Atorvastatin; D000077583:Quinapril